20/01/2023
Superbly well-connected
We’re in regular contact with senior officials in every relevant Government department and agency. Our public policy analyses have made us the natural choice for politicians to engage and consult with. Groups we’ve met, and will continue to meet, include:
The Prime Minister’s Taskforce on Innovation, Growth and Regulatory Reform
The Home Office’s THC consultation
The Government Chemist’s ring trial
17/01/2023
We inform and unite
We don’t believe those working in the sector should be doing so in isolation, so we host lots of networking events and webinars featuring exceptional speakers & panelists.
In 2021 we hosted the inaugural UK Medicinal Cannabis Summit in partnership with and NIHR
16/01/2023
Your representation in the corridors of power
Achieving modest shifts in policy, let alone the substantial changes we aspire to make, demands in-depth knowledge of both Westminster & Whitehall
Having access to decision-makers is equally important
We meet both criteria
21/12/2022
Great to have long standing members GROW Group on board!
GROW Group is part of many different industry organisations and working groups- one of which being the CMC ( ) 🌱
The CMC was founded in 2018 with the aim of representing the industry's members. The organisation is home to a whole host of medical experts and political knowledge, and they are in regular contact with various parts of the UK government such as the PM's Taskforce on Innovation, Growth and Regulatory Reform, and The Home Office’s THC consultation.
We're proud to be working with the team, and collaborating with other industry members!
19/12/2022
The Centre for Medicinal Cannabis (CMC) welcomes the Home Office's decision this week to request a review from the Advisory Council of the Misuse of Drugs (ACMD) on the current situation regarding schedule 1 drugs and the barriers to research. This includes synthetic cannabinoids and cannabis for research, when being developed for legitimate R&D purposes.
This case was made strongly in both recent reports produced by the CMC, Decalogue and The Hodges Review, where we outlined how the UK can become a world leader and global research hub for subsequent generations of cannabis based medicinal products.
Read our full statement via our website - link in bio
05/12/2022
The Centre for Medicinal Cannabis welcomes the positive legislative development to advance clinical understanding of medical cannabis in the United States. The new Medical Ma*****na Research Bill appointed by President Biden, will hopefully encourage the UK Government to consider the need for clinical trials and funding within Research and Development in Britain, and explore the impacts and huge potential of cannabis.
Link to the full press release via our stories
*****na *****na
28/11/2022
Its a beautiful morning in & the team are attending The Spectator Health Summit.
Bringing together and leaders to examine the priorities of the NHS. Looking at how and can help take the strain off some of the most stretched areas of the , and how the UK’s standing as a global superpower could benefit not only the NHS, but the UK in general.
15/11/2022
Our Company Secretary, Zehra Zahir is attending the MJBiz Con business & in Las Vegas over the next few days, & would love to hear from you if you're attending!
This 3-day conference is a great opportunity to stay informed on the cannabis market. With pre-show forums, 140 speakers, and an exhibition hall with over 1,400 organisations, its the prefect place to explore , -building opportunities and promote and discuss regulation and policy in the UK.
07/11/2022
A huge congratulations to the teams from & for the success of their Patient Conference on Friday.
A brilliantly organised event that really focused on the needs of patients. The panels throughout the day were informative and well presented, and really gave patients a voice. 👏🏼 👏🏼
It was also great to catch up with lots of industry representatives who we haven’t seen in a long time!
callieseaman
at
04/11/2022
A really important panel!Prescribing Cannabis: A Clinicians’ Perspective
“Medical cannabis doesn’t fit the mainstream medical framework, yet has an incredible potential to revolutionise current healthcare”
Katya Kowalski
A great panel chaired by with a mixture of patients, prescribers and industry representatives
04/11/2022
Today!
UK Patient Conference: Medical Cannabis Awareness Week 2022
Really looking forward to this event today in London! A chance for medical cannabis patients and prescribers to come together.
It’s also an amazing opportunity to promote the benefits of break down stigmas, and educate about cannabis-based medicines.
Our Comms Lead, Victoria Logan and our Research Lead Tom Risby are attending - see you all there!